Statements in which the resource exists.
SubjectPredicateObjectContext
pubmed-article:2591464rdf:typepubmed:Citationlld:pubmed
pubmed-article:2591464lifeskim:mentionsumls-concept:C1708335lld:lifeskim
pubmed-article:2591464lifeskim:mentionsumls-concept:C0025519lld:lifeskim
pubmed-article:2591464lifeskim:mentionsumls-concept:C0743223lld:lifeskim
pubmed-article:2591464lifeskim:mentionsumls-concept:C1521801lld:lifeskim
pubmed-article:2591464lifeskim:mentionsumls-concept:C0524474lld:lifeskim
pubmed-article:2591464pubmed:issue1lld:pubmed
pubmed-article:2591464pubmed:dateCreated1990-1-23lld:pubmed
pubmed-article:2591464pubmed:abstractTextThe pharmacokinetics of acetyl-L-carnitine hydrochloride were investigated in 6 healthy volunteers of both sexes after i.v. injection of 500 mg of the drug, expressed as inner salt. Plasma concentrations and urinary excretion of acetyl-L-carnitine (A), L-carnitine (B) and total acid soluble L-carnitine fraction were evaluated over a period lasting from 24 h before to 48 h after the administration. Plasma concentrations of A increased quickly after administration and then declined reaching base values within 12 h. Conversely, plasma concentrations of B rose more slowly, reaching a peak in 30-60 min, and then declined to base values within 24 h. Most of the injected dose of acetyl-L-carnitine was recovered in the urine during the first 24 h after administration as B and A. Mean renal clearance of both A and B during the first 12 h after injection was higher than the base values, suggesting the presence of a saturable tubular reabsorption process which may counterbalance major changes occurring in plasma concentrations of L-carnitine pattern.lld:pubmed
pubmed-article:2591464pubmed:languageenglld:pubmed
pubmed-article:2591464pubmed:journalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:2591464pubmed:citationSubsetIMlld:pubmed
pubmed-article:2591464pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:2591464pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:2591464pubmed:statusMEDLINElld:pubmed
pubmed-article:2591464pubmed:issn0031-6970lld:pubmed
pubmed-article:2591464pubmed:authorpubmed-author:KellyJ GJGlld:pubmed
pubmed-article:2591464pubmed:authorpubmed-author:RocchettiMMlld:pubmed
pubmed-article:2591464pubmed:authorpubmed-author:MarzoAAlld:pubmed
pubmed-article:2591464pubmed:authorpubmed-author:RizziNNlld:pubmed
pubmed-article:2591464pubmed:authorpubmed-author:Arrigoni...lld:pubmed
pubmed-article:2591464pubmed:authorpubmed-author:UrsoRRlld:pubmed
pubmed-article:2591464pubmed:issnTypePrintlld:pubmed
pubmed-article:2591464pubmed:volume37lld:pubmed
pubmed-article:2591464pubmed:ownerNLMlld:pubmed
pubmed-article:2591464pubmed:authorsCompleteYlld:pubmed
pubmed-article:2591464pubmed:pagination59-63lld:pubmed
pubmed-article:2591464pubmed:dateRevised2004-11-17lld:pubmed
pubmed-article:2591464pubmed:meshHeadingpubmed-meshheading:2591464-...lld:pubmed
pubmed-article:2591464pubmed:meshHeadingpubmed-meshheading:2591464-...lld:pubmed
pubmed-article:2591464pubmed:meshHeadingpubmed-meshheading:2591464-...lld:pubmed
pubmed-article:2591464pubmed:meshHeadingpubmed-meshheading:2591464-...lld:pubmed
pubmed-article:2591464pubmed:meshHeadingpubmed-meshheading:2591464-...lld:pubmed
pubmed-article:2591464pubmed:meshHeadingpubmed-meshheading:2591464-...lld:pubmed
pubmed-article:2591464pubmed:meshHeadingpubmed-meshheading:2591464-...lld:pubmed
pubmed-article:2591464pubmed:meshHeadingpubmed-meshheading:2591464-...lld:pubmed
pubmed-article:2591464pubmed:year1989lld:pubmed
pubmed-article:2591464pubmed:articleTitleMetabolism and disposition of intravenously administered acetyl-L-carnitine in healthy volunteers.lld:pubmed
pubmed-article:2591464pubmed:affiliationReal srl, Drug Metabolism and Pharmacokinetics Laboratory, Villaguardia, Como, Italy.lld:pubmed
pubmed-article:2591464pubmed:publicationTypeJournal Articlelld:pubmed